logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
23/03/2026
Market news: Saudi Arabia and Kuwait are currently trying to advance several energy agreements worth billions of dollars.
Latest
3 m ago
Commander of the Islamic Revolutionary Guard Corps Aerospace Force: The battle will continue until the national and patriotic goals are achieved.
4 m ago
Google's Wing will begin drone delivery service in the San Francisco Bay Area.
5 m ago
Market news: The French government has requested oil refining companies to increase production.
6 m ago
Sanhuan Group clarifies: rumors about media reports predicting a net loss in 2025 are not true.
11 m ago
According to the AI fast news, Huayuan Securities released a research report on March 23, giving Junshi Biosciences (688180.SH) a "buy" rating. The reasons for the rating include: 1) a well-known domestic innovative pharmaceutical company with a solid business foundation; 2) strong innovative pipeline strength, with the late-stage pipeline expected to gradually enter the realization period; 3) a differentiated early research pipeline with promising future prospects. (Daily Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.